Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: October 15, 2009
Last updated: April 27, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 27, 2015